HOME >> MEDICINE >> NEWS
First relapsing fever outbreak in Montana identified

A 2002 outbreak of tick-borne relapsing fever in Montana--the first confirmation of relapsing fever in the state--has led to the discovery of a bacterium and species of tick not known previously to exist in Montana.

In the September 2003 issue of the journal Emerging Infectious Diseases, investigators at Rocky Mountain Laboratories (RML) in Hamilton, Montana, and their collaborators describe this outbreak and the results of laboratory and clinical investigations.

"Given the 100-year history of research into ticks and tick-borne diseases in Montana, we are gratified to have helped solve the mystery of this outbreak and to have identified a focus of this disease as well as the bacterium and tick in our back yard," states Tom G. Schwan, Ph.D., lead investigator of the study. RML, which began by conducting pioneering studies in Montana on Rocky Mountain spotted fever, is part of the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health in Bethesda, MD.

"This investigation demonstrates once again the potential for diseases to emerge unpredictably in areas where they have not been recognized previously," notes Marshall Bloom, M.D., associate director of RML. "These findings will also alert health care providers in this region that relapsing fever bacteria may cause a recurrent febrile illness, which is curable when recognized and treated promptly with antibiotics."

The mystery presented itself between July and August 2002, when five of 20 people became ill during or after visiting a cabin on an island in Flathead Lake in western Montana. RML investigators and tick experts Dr. Schwan and Paul Policastro, Ph.D., worked with physicians in Seattle; Montana State Epidemiologist Todd Damrow, Ph.D.; the Lake County Health Department; and the curator of the U.S. National Tick Collection to determine the cause of the outbreak.

The patients, between 5 and 54 years old, experienced
'"/>

Contact: NIAID Office of Communications and Public Liaison
niaidnews@niaid.nih.com
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
26-Aug-2003


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. First UK cases of previously rare disease reported in gay men
3. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
4. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
5. First US kidney cancer vaccine trial underway at Columbia
6. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
7. First blood test to diagnose paralyzing, blinding disease
8. First US SARS vaccine trial opens at NIH
9. First-ever safety study of medical cannabis use in Canada launched
10. First solid evidence that the study of music promotes intellectual development
11. First medical test on CD gets good results

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: First relapsing fever outbreak Montana identified

(Date:5/21/2013)... The birth control safety advocates at DrugRisk.com ... the contraceptive NuvaRing. A new report shows the number ... increased in recent months*. , DrugRisk was created to ... the latest safety alerts, recalls, studies and legal news. ... side effects and decide if they need legal advice. ...
(Date:5/20/2013)... May 21, 2013 USA Book News ... Approach to Peak Performance" won the top honor in ... Chosen over a multitude of international titles published ... and critical acclaim from both mainstream and new age ... mentally, physically and spiritually. , “The Infinity ...
(Date:5/20/2013)... Texas (PRWEB) May 21, 2013 ... on product type into two categories - semi-automated ... market is classified into five categories, namely, hospitals, ... market is forecast till 2017. Automated external defibrillators ... of sudden cardiac arrest victims. Considering the life-saving ...
(Date:5/20/2013)... Los Angeles, CA (PRWEB) May 20, 2013 ... light on the importance of using green and ... Canadian federal government has implemented regulations to promote ... for the Packaging and Labelling Services industry ... also supported this trend,” says IBISWorld industry analyst ...
(Date:5/20/2013)... In order to prepare for the long hot ... DrSmartphoneMD launched an article series to raise awareness about skincare ... launched with the precautions that need to be taken ... are not one of the 3.5 million cases of skin ... of all skin cancer cases are associated with exposure to ...
Breaking Medicine News(10 mins):Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Combat Skin Cancer In Summer Months 2
(Date:5/20/2013)... 2013 /PRNewswire-iReach/ -- Specific Technologies, today announced the ... detection of pathogenic bacteria, including potential bioterrorism agents ... Bacillus anthracis which feature on the Center ... bio-threats. This seminal study, conducted in collaboration with ... Salisbury (DSTL), United Kingdom ...
(Date:5/20/2013)... YORK , May 20, 2013  Echo Pharma ... 2.5 of the Irish Takeover Rules (the "Announcement"), a ... plc (NYSE: ELN ) to $12.50 per ... cash confirmed and not conditional on due diligence.  The ... Royalty Pharma has reserved the right to waive down ...
(Date:5/20/2013)... Mai 2013 Sequent Medical, Inc. ... CE-Kennzeichnung für die SL-Produktfamilie („Single Layer") seiner ... hat. Das Unternehmen hat in ausgewählten neurovaskulären ... Einführung dieser neuen Modelle begonnen. Neben einem ... verbessertes Handling, das es Ärzten ermöglicht, ein ...
Breaking Medicine Technology:Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3
Cached News: